This entry was posted on March 18, 2009 at 8:18 am and is filed under AKT, GSK.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
Glaxo published lots of stuff around the aminofurazane monsters, also for Rho kinase if i remember correctly. And those series were also discontinued, for animal toxicity reasons. They were not sure if the problem mechanism based. But just looking at the structure one can suffer a seizure.